FDA Investigator David R Delucia

David R Delucia has inspections in 2 countries as of 07 Nov 2023. David R Delucia has collaborated with a combinined 3394 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
141
Last Inspection Date:
07 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Alejandra Mcclellan, Alice S Tsao, Althea A Williams, Amatul H Marium, Amber D Brodas, Amy Kim, Amy W Yan Mai, Andrew F Cohen, Andrew J Molesky, Ann B Okon, Ann M Stewart, Anne E Carpenter, Anthony M Criscuolo, Jr, Anthony R Rauert, Antoinette O Smallhorne, Arduino Frankovic, Ashley Polizzotto, Ayorinde O Babalola, Aziz A Mamur, Benjamin Bustamante, Bijoy Panicker, Brandy N Lepage, Brian M Brodman, Brittney Hu, Carr, Catherine M Beer, Charanjeet Jassal, Charisse K Green, Christian Parra, Christine M Rivera, Coleburn E Vielehr, David A Carlson, David H Smith, Demitria J Xiradakis, Devina K Budhan, Diane B Radice, Diane C Thibodeau, Dipesh K Shah, Donald G Gordon, Dongping Dai, PhD, Dr. Robert C Horan, MD, Edouard Viard, Edwin A Evangelista, Elizabeth H Slazak, Emilio Z Azukwu, Erin L Nagel, Evan Tong, Evelyn Taha, Felix Maldonado, Frank Verni, Gabriel Feng, Gam S Zamil, Gary J Lader, Gary J Lehr, Gary T Greco, Gianine E Tompkins, Gray, Gregson A Joseph, Guerlain Ulysse, Harry J Brewer, Hien Albright, Iram R Hassan, PhD, Irina Gaberman, Jacqueline S Warner, James A Liubicich, James D Bridges, Jana J Lau, Jananiga Vanniyasingam, Jane Chen, Jason Kwong, Jay T Wong, Jennifer J Edmiston, Jessica M Monteiro, Joel R Merriman, John A Podsadowski, Jose O Hernandez, Joseph Duca, Joseph H Procopio, Joseph Maselli, Joy P Matthias, Juan Rjimenez Garcia, Judy Keihl, Justin A Boyd, Karen F Tomaziefski, Karen L Kosar, Karishma G Gopaul, Kenneth H Williams, Kerry A Kurdilla, Kerry D Noto, Kevin A Gonzalez, Kim Lthomas Cruse, Kim M Downing, Kim Thomasc Rice, Kimberley A Ricketts, Kimberly A Coward, Kwong P Lee, Lauren E Blaser, Lawrence Farine, Lawrence R Johnson, Lawrence W Farina, LCDR Chad N Thompson, Linda M Sacco, Lydia E Gonzalez, Marc S Neubauer, Margaret E Sarles, Marlene L Davis, Matthew A Spataro, Matthew D Schnittker, Meisha A Mandal, Melissa B Libby, Melka F Argaw, Meredith P Soehl, Investigator, Michael A Charles, Michael G Sinkevich, Michael Levin, Michael R Dominick, Michael S Chuley, Michael W Burd, Michele C Murray Schrade, Mindy M Chou, Morgan J Matthews, Mouhamed H Halwani, Nancy A Saxenian Emmons, Nazmul Hassan, Neil J Bonzagni, PhD MPH, Nerizza B Guerin, Nicholas C Mendiola, Nicholas J Morici, Nicole Vaught, Omadevi Somai, Investigator, Omolola A Shola Philips, Parul M Patel, Patrick C Klotzbuecher, Paul E Stein, Paul Mouris, Perry T Nichols, Peter Abel, Peter Caparelli, Peter M Trunk, Peter R Caparelli, Philip F Istafanos, DMV, MS, Phyllis J Wilson, Rachael A Moliver, Raihan A Chowdhury, Rajiv R Srivastava, Randolph Campos Santiago, Raymond Liu, Richard D Manney, Richard Ferfoglia, Rita F Monfort, Robert C Steyert, Robert E Moncayo, Rochelle K Kimmel, Ronald Ifraimov, Samina S Khan, Samuel A Francis, Samuel T Walker, Sarah A Meehan, Sarah K Graham, Satheesh Thomas, Schultz, Scott R Izyk, Seemay A Lee, Shari L Kahn, Sharon Ferraro, Simone E Pitts, Sony Mathews, State Agency, Stephanie T Durso, Steven M Weinman, Sunita Vij, Susan M Joseph, Susan W Ting, Susant Hadman, Syeda N Mahazabin, Taina Pierre Pierre, Tanvir Kaium, Tanya R Syffrard, Tara K Carmody, Tara K Normandin, Terry Bridgewater, Thomas Cote, Thomas J Mooney, Tracy M Portelli, Uduak M Inokon, Valerie C Reed, Vanessa M Williams, Vincent T Duncan, Wai H Lam, Wayne J Meyer, Weston K Szymanski, William K Dagley, William V Thompson, Willy A Orantes, Xiaoping Guan, Yuyan Liang

David R Delucia's Documents

Publish Date Document Type Title
July, 2001 FDA 483 C.R. Bard Inc. - Form 483, 2001-07-13
March, 2001 FDA 483 Taro Pharmaceutical Laboratories, Inc. - Form 483, 2001-03-23
November, 2001 FDA 483 Kaufmans Bakery Inc - Form 483, 2001-11-13
July, 2000 FDA 483 Jerome Stevens Pharmaceuticals, Inc. - Form 483, 2000-07-26
July, 2000 EIR Jerome Stevens Pharmaceuticals, Inc. - EIR, 2000-07-26
June, 2002 EIR Contract Pharmacal Corp. - EIR, 2002-06-20
November, 2000 FDA 483 Alden Optical - Form 483, 2000-11-03
January, 2000 EIR Contract Pharmacal Corp. - EIR, 2000-01-21
November, 2001 EIR Kaufmans Bakery Inc - EIR, 2001-11-13
April, 2000 EIR Taro Pharmaceutical Laboratories, Inc. - EIR, 2000-04-05
September, 2000 EIR Contract Pharmacal Corp. - EIR, 2000-09-01
May, 2000 FDA 483 Jerome Stevens Pharmaceuticals, Inc. - Form 483, 2000-05-04
October, 2000 FDA 483 Pharma Tech Products, LLC - Form 483, 2000-10-27
January, 2001 EIR Contract Pharmacal Corp. - EIR, 2001-01-12
October, 2000 FDA 483 Response Pharma Tech Products, LLC - Form 483R, 2000-12-08
July, 2000 FDA 483 Response Jerome Stevens Pharmaceuticals, Inc. - Form 483R, 2000-09-21
January, 2000 FDA 483 Richmond Wholesale, Inc. - Form 483, 2000-01-07
January, 2001 FDA 483 Contract Pharmacal Corp. - Form 483, 2001-01-12
September, 2000 FDA 483 Contract Pharmacal Corp. - Form 483, 2000-09-01
April, 2000 FDA 483 Taro Pharmaceutical Laboratories, Inc. - Form 483, 2000-04-05
July, 2000 EIR LNK International, Inc. - EIR, 2000-12-05
July, 2001 EIR C.R. Bard Inc. - EIR, 2001-07-13
May, 2000 EIR Jerome Stevens Pharmaceuticals, Inc. - EIR, 2000-05-04
October, 2000 FDA 483 Taro Pharmaceutical Laboratories, Inc. - Form 483, 2000-10-12
September, 2000 FDA 483 Response Contract Pharmacal Corp. - Form 483R, 2000-11-09
April, 2000 FDA 483 Response Taro Pharmaceutical Laboratories, Inc. - Form 483R, 2000-08-16

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more